Q3-2008. Dr. Paul Dunn has joined the Genomics USA team as ASHI Director and HLA Advisor.

Q3-2008. Genomics USA received a Notice of Intent to grant the European patent application No. 02748133.2 titled “Methods and Devices Based Upon A Novel Form of Nucleic Acid Duplex On A Surface”.

Q2- 2008. Genomics USA was awarded the US patent on April 8, 2008 No. 7354710 titled “ Methods and Devices Based Upon A Novel Form of Nucleic Acid Duplex On A Surface”.

Q3-2006. GENUSA receives funding of about $3 million for 3 years effective from September 1, 2006 for its Phase 2 grant "Population-scale HLA typing for home land defense.

Q2-2006. GENUSA receives funding from QuantRx BioMedical Corporation.

Q2-2004. GENUSA SBIR Phase I grant "Population-scale HLA typing for home land defense," is funded by NIAID, effective May 1, 2004. for $498,500.

Q3-2003. GENUSA is awarded a seed grant from Chicago ITEC to continue its feasibility studies.